Supportive treatment for cast nephropathy in patients with multiple myeloma; a pilot study

• Hauptverfasser: Giovanni Cancarini (VerfasserIn), Vincenzo Terlizzi (VerfasserIn), Anna Garatti (VerfasserIn), Letizia Zeni (VerfasserIn), Mattia Tonoli (VerfasserIn), Elena Pezzini (VerfasserIn), Francesca Boni (VerfasserIn), Stefano Possenti (VerfasserIn), Battista Fabio Viola (VerfasserIn), Mario Gaggiotti (VerfasserIn)
• Format: Buch
• Veröffentlicht: Society of Diabetic Nephropathy Prevention, 2021-05-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Introduction: Cast nephropathy is a prevalent cause of acute kidney injury (AKI) in patients with myeloma. Objectives: The aim of this study is to define the outcome of a standardized supportive therapy for cast nephropathy. Patients and Methods: Retrospective analysis of the outcome of cast nephrop...